Clinical trials are highly organized studies of medications or medical devices. Though the trials are structured and planned by a sponsoring pharmaceutical company, all the clinical trials that we participate in are closely supervised and approved by the US Food & Drug Administration.
Leading pharmaceutical companies have recognized the expertise and experience of Dundee Dermatology for participation in their FDA-approved research trials. Though there can be both benefits and risks to a clinical trial, a primary advantage to patients is that trials can provide access to treatments and medications that are not yet widely available.
Dundee Dermatology is recognized for expertise in several common but troublesome dermatologic conditions and serves as a clinical research resource for these conditions. We have conducted a broad range of studies in phases II through IV of study development and continue active participation in dermatology research efforts in Chicago for a range of skin conditions.
Previous Sponsored Clinical Research Studies Have Included:
- 12/2021 – present Eli Lilly and Company – Phase III – Atopic Dermatitis
- 10/2021 – present Amgen – Phase III – Psoriasis
- 05/2021 – present Pfizer – Phase III – Atopic Dermatitis
- 05/2021 – present Eli Lilly and Company – Phase III – Atopic Dermatitis
- 09/2020 – present Novartis– Phase III – Hidradenitis Suppurativa
- 02/2020 – present Bristol Myers Squibb – Phase III – Psoriasis
- 08/2019 – present Novartis – Phase III – Hidradenitis Suppurativa
- 06/2019 – 12/2020 Pfizer – Phase IIb – Psoriasis
- 06/2019 – 06/2020 Pfizer – Phase III – Atopic Dermatitis
- 12/2018 – 04/2021 Amgen – Phase II – Atopic Dermatitis
- 10/2018 – 01/2021 Bristol Myer Squibb – Phase III – Psoriasis
- 05/2018 – 07/2019 Dermira– Phase IIB – Atopic Dermatitis
- 12/2017 – 10/2018 Foamix Pharmaceuticals – Phase III – Acne Vulgaris
- 02/2017 – 05/2018 Pfizer – Phase IIA – Psoriasis
- 06/2017 – present Boehringher Ingelheim – Phase III – Psoriasis
- 04/2016 – 10/2017 Regeneron – Phase III – Atopic Dermatitis
- 04/2016 – 06/2017 Pfizer – Phase IIB – Atopic Dermatitis
- 06/2015 – 04/2016 DS Biopharma – Phase II – Atopic Dermatitis
- 05/2015 – 03/2019 UCB, Inc. – Phase III – Psoriasis
- 02/2015 – 09/2015 Pfizer – Phase II – Psoriasis
- 12/2014 – 12/2016 Regeneron – Phase III – Atopic Dermatitis
- 08/2014 – 08/2016 Sandoz – Phase III – Psoriasis
- 03/2013 – 01/2020 Merck & Co, Inc. – Phase III – Psoriasis
- 08/2012 – 11/2015 Amgen Inc. – Phase III – Psoriasis
- 05/2011 – 08/2016 Pfizer – Phase III – Psoriasis
- 02/2011 – 09/2015 Celgene Corporation – Phase III – Psoriasis
- 08/2013 – 12/2014 Pfizer – Phase IIB – Psoriasis
- 07/2013 – 12/2014 AstraZeneca – Phase IIA – Hidradenitis Suppurativa
- 07/2011 – 12/2013 Pfizer – Phase III – Psoriasis
- 06/2010 – 04/2011 Eli Lilly and Company – Phase II – Psoriasis
- 01/2009 – 12/2010 Basilea Pharmaceutica AG – Phase III – Hand Eczema
- 06/2008 – 08/2009 Pfizer Inc – Phase II – Psoriasis
- 06/2008 – 06/2009 Abbott Laboratories – Phase III – Psoriasis
- 05/2008 – 06/2009 Abbott Laboratories – Phase III – Psoriasis
- 02/2008 – 11/2011 Centocor Ortho Biotech Inc – Phase IV – Psoriasis Registry
- 02/2008 – 08/2009 Abbott Laboratories – Phase III – Psoriasis
- 08/2007 – 02/2012 Centocor Ortho Biotech Inc– Phase IV – Psoriasis
- 12/2006 – 04/2007 Obagi Medical Products, Inc – Phase IV – Acne Vulgaris
- 02/2006 – 06/2006 Amgen Inc – Phase IV – Psoriasis
- 04/2004 – 10/2007 Immunex Corp Phase III – Psoriasis
- 02/2004 – 10/2004 Amgen – Phase III – Psoriasis
- 06/2003 – 06/2004 Genentech, Inc – Phase III – Psoriasis
- 06/2003 – 06/2005 Biogen Idec, Inc – Phase IV – Psoriasis Registry
If you would like to learn more about our clinical research trials, contact our Clinical Research Coordinator, JoAnn Hawkinson BSN, at 847-350-1195.